Administration-time-dependent effects of diltiazem on the 24-hour blood pressure profile of essential hypertension patients

被引:29
作者
Kohno, I
Iwasaki, H
Okutani, M
Mochizuki, Y
Sano, S
Satoh, Y
Ishihara, T
Ishii, H
Mukaiyama, S
Ijiri, H
Komori, S
Tamura, K
机构
[1] Second Dept. of Internal Medicine, Yamanashi Medical University, Tamaho, Nakakoma, Yamanashi, 409-38
关键词
chronotherapy; calcium channel blocker; diltiazem; hypertension; nocturnal hypertension; circadian rhythm;
D O I
10.3109/07420529709040543
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The aim of this study was to identify differences in the patterns of efficacy and duration of effect by diltiazem given in different dosage forms and schedules. Blood pressure (BP) and heart rate (HR) were monitored before and after treatment by ambulatory blood pressure monitoring for 48 h every 30 min. Patients were divided for treatment assignment into 4 groups-nocturnal BP dippers and nondippers. In dipper hypertension, diltiazem-retard at 08:00 (n = 7) had the most marked antihypertensive effects during nighttime rest (SEP; 136 +/- 14/118 +/- 9 mmHg, p < 0.01 before vs. after treatment). Diltiazem-retard at 19:00 (a = 6) exerted greatest effect during daytime activity (152 +/- 7/139 +/- 6, p < 0.01) with inhibition of the morning BP rise. Diltiazem (t.i.d., n = 5) had the best effect during daytime activity (151 +/- 16/136 +/- 9, p < 0.05). However, in nondipper hypertensive patients, diltiazem (t.i.d., n = 8) had the most pronounced antihypertensive effects during nightly rest (144 +/- 12/127 +/- 12, p < 0.05). Evening medication with diltiazem retard appears to be more efficacious than the other dosage schedules.
引用
收藏
页码:71 / 84
页数:14
相关论文
共 25 条
  • [1] 24 HOUR AMBULATORY BLOOD-PRESSURE PROFILE OF A NEW SLOW-RELEASE FORMULATION OF DILTIAZEM IN MILD TO MODERATE HYPERTENSION
    DUPONT, AG
    COUPEZ, JM
    JENSEN, P
    COUPEZLOPINOT, R
    SCHOORS, DF
    HERMANNS, P
    NICOLAS, M
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1991, 5 (04) : 701 - 707
  • [2] ETOH A, 1980, BASIC CLIN, V14, P328
  • [3] FLAMENBAUM W, 1990, J CLIN PHARMACOL, V30, P856
  • [4] KAINUMA T, 1989, CLIN MED PHARM, V5, P19
  • [5] KAINUMA T, 1987, CLIN INVESTIGATOR, V64, P4003
  • [6] PHARMACOKINETIC PROPERTIES AND ANTIHYPERTENSIVE EFFICACY OF ONCE-DAILY DILTIAZEM
    KELLY, JG
    DEVANE, JG
    GEOGHEGAN, B
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (06) : 957 - 963
  • [7] COMPARATIVE EFFECTS OF DILTIAZEM SUSTAINED-RELEASE FORMULATION AND METOPROLOL ON AMBULATORY BLOOD-PRESSURE AND PLASMA-LIPOPROTEINS
    LACOURCIERE, Y
    POIRIER, L
    BOUCHER, S
    SPENARD, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) : 318 - 324
  • [8] THE USE OF CONFIDENCE-INTERVALS TO DESCRIBE THE PRECISION OF TROUGH/PEAK RATIOS FOR DILTIAZEM CD IN THE TREATMENT OF HYPERTENSION
    MEEVES, SG
    PARK, GD
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (03) : 231 - 235
  • [9] MOOSER V, 1988, J HUM HYPERTENS, V2, P257
  • [10] CIRCADIAN VARIATION IN THE FREQUENCY OF ONSET OF ACUTE MYOCARDIAL-INFARCTION
    MULLER, JE
    STONE, PH
    TURI, ZG
    RUTHERFORD, JD
    CZEISLER, CA
    PARKER, C
    POOLE, WK
    PASSAMANI, E
    ROBERTS, R
    ROBERTSON, T
    SOBEL, BE
    WILLERSON, JT
    BRAUNWALD, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (21) : 1315 - 1322